Mutation of a serine near the catalytic site of the choline acetyltransferase a gene almost completely abolishes motility of the zebrafish embryo
- Joshi, S., Virdi, S., Etard, C., Geisler, R., Strähle, U.
- PLoS One 13: e0207747 (Journal)
- Registered Authors
- Etard, Christelle, Geisler, Robert, Joshi, Swarnima, Strähle, Uwe, Virdi, Sanamjeet
- MeSH Terms
- Amino Acid Sequence
- Amino Acid Substitution
- Catalytic Domain*
- Choline O-Acetyltransferase/chemistry*
- Choline O-Acetyltransferase/genetics*
- Choline O-Acetyltransferase/metabolism
- Embryo, Nonmammalian/physiology*
- Enzyme Stability
- Mutation, Missense
- Protein Structure, Secondary
- 30458023 Full text @ PLoS One
Joshi, S., Virdi, S., Etard, C., Geisler, R., Strähle, U. (2018) Mutation of a serine near the catalytic site of the choline acetyltransferase a gene almost completely abolishes motility of the zebrafish embryo. PLoS One. 13:e0207747.
In zebrafish, the gene choline acetyltransferase a (chata) encodes one of the two ChAT orthologs responsible for the synthesis of acetylcholine. Acetylcholine (ACh) is essential for neuromuscular transmission and its impaired synthesis by ChAT can lead to neuromuscular junction disorders such as congenital myasthenic syndromes in humans. We have identified a novel mutation in the chata gene of zebrafish, chatatk64, in a collection of uncharacterised ENU-induced mutants. This mutant carries a missense mutation in the codon of a highly conserved serine changing it to an arginine (S102R). This serine is conserved among ChATs from zebrafish, rat, mice and chicken to humans. It resides within the catalytic domain and in the vicinity of the active site of the enzyme. However, it has not been reported so far to be required for enzymatic activity. Modelling of the S102R variant change in the ChAT protein crystal structure suggests that the change affects protein structure and has a direct impact on the catalytic domain of the protein which abolishes embryo motility almost completely.
Genes / Markers
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Engineered Foreign Genes